Aptamedicine: a new treatment modality in personalized cancer therapy
Aptamers (Aps) are short single-strand nucleic acids exhibiting unique 3D structure which facilitate their targeting potential against various cancer molecular markers (CMMs). Such features of Aps not only make them as suitable homing agents in targeted drug delivery systems (DDSs) but also candidat...
Main Authors: | Somayeh Vandghanooni, Morteza Eskandani, Jaleh Barar, Yadollah Omidi |
---|---|
Format: | Article |
Language: | English |
Published: |
Tabriz University of Medical Sciences
2019-03-01
|
Series: | BioImpacts |
Subjects: | |
Online Access: | https://bi.tbzmed.ac.ir/PDF/bi-9-67.pdf |
Similar Items
-
Mucin-1 aptamer-armed superparamagnetic iron oxide nanoparticles for targeted delivery of doxorubicin to breast cancer cells
by: Ayuob Aghanejad, et al.
Published: (2018-03-01) -
Translational Approaches towards Cancer Gene Therapy: Hurdles and Hopes
by: Yadollah Omidi, et al.
Published: (2012-09-01) -
Combating atherosclerosis with targeted nanomedicines: recent advances and future prospective
by: Ailar Nakhlband, et al.
Published: (2018-01-01) -
Surface modified multifunctional nanomedicines for simultaneous imaging and therapy of cancer
by: Jaleh Barar, et al.
Published: (2014-03-01) -
Impacts of Blood-Brain Barrier in Drug Delivery and Targeting of Brain Tumors
by: Yadollah Omidi, et al.
Published: (2012-02-01)